This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Samsung Electronics Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Hyun-min Koo: Innovator in Microbial Biotechnology
Introduction
Hyun-min Koo is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of microbial biotechnology, particularly in the area of 1,4-butanediol (1,4-BDO) production. With a total of 2 patents, Koo's work has the potential to impact various industrial applications.
Latest Patents
Koo's latest patents include a mutant microorganism that exhibits improved 1,4-BDO productivity and a method for preparing 1,4-BDO using this mutant microorganism. This invention involves a recombinantly modified microorganism with enhanced productivity compared to its unmodified counterpart. The modification includes the inactivation or reduction of an enzyme that catalyzes the conversion reaction between malate and oxaloacetate. Additionally, he has developed a method for constructing recombinant organisms using multiple genes co-integration. This method allows for the simultaneous co-integration of multiple nucleic acid sequences into a microbial organism, facilitating advancements in genetic engineering.
Career Highlights
Hyun-min Koo is currently employed at Samsung Electronics Co., Ltd., where he continues to innovate in the field of biotechnology. His work is characterized by a focus on enhancing microbial processes for industrial applications.
Collaborations
Koo collaborates with notable colleagues, including Jae-chan Park and Soon-chun Chung, who contribute to his research and development efforts.
Conclusion
Hyun-min Koo's contributions to microbial biotechnology, particularly in the production of 1,4-BDO, highlight his role as an influential inventor in the field. His innovative approaches and collaborations continue to drive advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
